Bornstein, J <br/><br/>
Clobetasol dipropionate 0.05% versus testosterone propionate 2% topical application for severe vulvar lichen sclerosus.  [electronic resource] 

 -  American journal of obstetrics and gynecology  Jan 1998 
 - 80-4 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0002-9378 
<br/><br/><label>Standard No.: </label>10.1016/s0002-9378(98)70631-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Topical<br/>Aged<br/>Anti-Inflammatory Agents--administration & dosage<br/>Carcinoma, Squamous Cell--diagnosis<br/>Clobetasol--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Incidence<br/>Lichen Sclerosus et Atrophicus--drug therapy<br/>Middle Aged<br/>Testosterone--administration & dosage<br/>Treatment Outcome<br/>Vulvar Diseases--drug therapy<br/>Vulvar Neoplasms--diagnosis